Literature DB >> 18178833

Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.

Kunio Hieshima1, Daisuke Nagakubo, Takashi Nakayama, Aiko-Konno Shirakawa, Zhe Jin, Osamu Yoshie.   

Abstract

Adult T cell leukemia is a mature CD4+ T cell malignancy which predominantly expresses CCR4 and is etiologically associated with human T cell leukemia virus type 1 (HTLV-1). Because HTLV-1 transmission depends on close cell-cell contacts, HTLV-1-infected T cells may preferentially interact with CCR4+CD4+ T cells for efficient viral transmission. In terms of gene expression and protein secretion, we found a strong correlation between HTLV-1 Tax oncoprotein and CCL22, a CCR4 ligand, in HTLV-1-infected T cells. Transient Tax expression in an HTLV-1-negative T cell line activated the CCL22 promoter and induced CCL22. Additionally, tax gene knockdown by small interference RNA reduced CCL22 expression in the infected T cells. These findings indicate that CCL22 is a cellular target gene of Tax. In chemotaxis assays, the culture supernatants of HTLV-1-infected T cells selectively attracted CCR4+CD4+ T cells in PBMCs. This was blocked by pretreating the supernatants with anti-CCL22 Ab or PBMCs with a synthetic CCR4 antagonist. In coculture experiments, primary CCR4+CD4+ T cells significantly adhered to Tax-expressing cells. This adhesion was blocked by the CCR4 antagonist or pertussis toxin. Interestingly, CCR4 was redistributed to the contact region, and in some cases, this was accompanied by a polarized microtubule-organizing center, which is an indicator of virological synapse formation, in the infected T cells. Finally, anti-CCL22 Ab treatment also blocked HTLV-1 transmission to primary CD4+ T cells in coculture experiments with HTLV-1 producer cells. Thus, HTLV-1-infected T cells produce CCL22 through Tax and selectively interact with CCR4+CD4+ T cells, resulting in preferential transmission of HTLV-1 to CCR4+CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178833     DOI: 10.4049/jimmunol.180.2.931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells.

Authors:  Ryuichiro Kimura; Masachika Senba; Samuel J Cutler; Stephen J Ralph; Gutian Xiao; Naoki Mori
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Authors:  Andrea K Kress; Grit Schneider; Klemens Pichler; Martina Kalmer; Bernhard Fleckenstein; Ralph Grassmann
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

3.  Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.

Authors:  Ana Laura Fazio; Wesley Kendle; Kimson Hoang; Erica Korleski; Isabelle Lemasson; Nicholas Polakowski
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.

Authors:  Natsumi Araya; Tomoo Sato; Hitoshi Ando; Utano Tomaru; Mari Yoshida; Ariella Coler-Reilly; Naoko Yagishita; Junji Yamauchi; Atsuhiko Hasegawa; Mari Kannagi; Yasuhiro Hasegawa; Katsunori Takahashi; Yasuo Kunitomo; Yuetsu Tanaka; Toshihiro Nakajima; Kusuki Nishioka; Atae Utsunomiya; Steven Jacobson; Yoshihisa Yamano
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 5.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464

6.  Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.

Authors:  Frederic Toulza; Kisato Nosaka; Yuetsu Tanaka; Tiziana Schioppa; Frances Balkwill; Graham P Taylor; Charles R M Bangham
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

7.  HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.

Authors:  Yorifumi Satou; Atae Utsunomiya; Junko Tanabe; Masanori Nakagawa; Kisato Nosaka; Masao Matsuoka
Journal:  Retrovirology       Date:  2012-05-30       Impact factor: 4.602

8.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

Review 9.  Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.

Authors:  Masaya Higuchi; Masahiro Fujii
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

10.  Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.

Authors:  Fabio E Leal; Lishomwa C Ndhlovu; Aaron M Hasenkrug; Fernanda R Bruno; Karina I Carvalho; Harry Wynn-Williams; Walter K Neto; Sabri S Sanabani; Aluisio C Segurado; Douglas F Nixon; Esper G Kallas
Journal:  PLoS Negl Trop Dis       Date:  2013-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.